2014 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of study are Virology, Virus, Immunology, Epstein–Barr virus and Molecular biology. His Virology research integrates issues from Cell culture, Gene, Transfection and Antibody. His biological study spans a wide range of topics, including Disease and Pathogenesis.
His studies link Cytotoxic T cell with Immunology. The study incorporates disciplines such as Lytic cycle, Lymphoproliferative disorders, Lymphoma and Gammaherpesvirinae in addition to Epstein–Barr virus. His Molecular biology research incorporates elements of Recombinant virus, Recombinant DNA, Interleukin-21 receptor, Complementary DNA and In vivo.
His primary scientific interests are in Virology, Virus, Immunology, Varicella zoster virus and Molecular biology. His Virology research is multidisciplinary, incorporating elements of Antibody and Gene. The various areas that he examines in his Virus study include Open reading frame, Cell culture and Mutant.
Immunology is closely attributed to Disease in his study. His study in Varicella zoster virus is interdisciplinary in nature, drawing from both Immediate early protein, Kinase and Chickenpox. His Molecular biology research is multidisciplinary, relying on both RNA, Apoptosis, Transfection, Transactivation and Complementary DNA.
Jeffrey I. Cohen focuses on Virology, Immunology, Virus, Antibody and Immune system. His Herpes simplex virus and Epstein–Barr virus infection study, which is part of a larger body of work in Virology, is frequently linked to Coronavirus and Severe acute respiratory syndrome coronavirus 2, bridging the gap between disciplines. Jeffrey I. Cohen combines subjects such as Hemophagocytic lymphohistiocytosis, Disease and Case-control study with his study of Immunology.
Many of his studies involve connections with topics such as Cell biology and Virus. The concepts of his T cell study are interwoven with issues in Protein kinase domain, Cancer research and Common variable immunodeficiency. His research in the fields of BZLF1 overlaps with other disciplines such as Nasopharyngeal carcinoma.
The scientist’s investigation covers issues in Immunology, Virology, Virus, Antibody and Epstein–Barr virus. His Immunology study combines topics in areas such as Disease and CD38. His Virology research includes themes of Epitope and Immunity.
His Virus study incorporates themes from Hematopoietic stem cell transplantation and Lymphoproliferative disorders, Lymphoma. His study in the field of Viral Vaccine also crosses realms of Coronavirus. His Epstein–Barr virus research includes elements of Genome, Diffuse large B-cell lymphoma and B cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
S. Hacein-Bey-Abina;C. Von Kalle;C. Von Kalle;M. Schmidt;M. P. McCormack.
Epstein-Barr Virus Infection
Jeffrey I. Cohen.
The New England Journal of Medicine (2000)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Paul Bastard;Paul Bastard;Paul Bastard;Lindsey B. Rosen;Qian Zhang;Eleftherios Michailidis.
Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor.
Zhengbin Yao;William C. Fanslow;Michael F. Seldin;Anne Marie Rousseau.
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
L Young;C Alfieri;K Hennessy;H Evans.
The New England Journal of Medicine (1989)
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
Jeffrey I. Cohen;Fred Wang;Joan Mannick;Elliott Kieff.
Proceedings of the National Academy of Sciences of the United States of America (1989)
Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis
John Bertin;Robert C. Armstrong;Sabine Ottilie;David A. Martin.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Clinical practice: Herpes zoster.
Jeffrey I Cohen.
The New England Journal of Medicine (2013)
Second messenger role for Mg2+ revealed by human T-cell immunodeficiency
Feng-Yen Li;Benjamin Chaigne-Delalande;Chrysi Kanellopoulou;Jeremiah C. Davis.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: